Benchmark analyst Bill Sutherland lowered the firm’s price target on Surgery Partners (SGRY) to $35 from $40 and keeps a Buy rating on the ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TG Therapeutics (TGTX – Research Report), ...
TipRanks on MSN13h
Surgery Partners Reports Strong Revenue Growth for 2024Surgery Partners Inc. ( ($SGRY) ) has released its Q4 earnings. Here is a breakdown of the information Surgery Partners Inc. presented to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback